Percutaneous pulmonary valve implantation: Current status and future perspectives

Bart Driesen; Evangeline Warmerdam; Gertjan Tj  Sieswerda; Folkert Meijboom; Mirella Molenschot; Gregor Krings; A.P. Dijk; Michiel Voskuil

doi:10.2174/1573403X15666181224113855

Percutaneous pulmonary valve implantation: Current status and future perspectives

Bart Driesen
, Evangeline Warmerdam
, Gertjan Tj Sieswerda
, Folkert Meijboom
, Mirella Molenschot
, Gregor Krings
, A.P. Dijk
, Michiel Voskuil

Research output: Contribution to journal › Review article › peer-review

9 Citations (Scopus)

Abstract

Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

Original language	English
Pages (from-to)	262-273
Number of pages	12
Journal	Current Cardiology Reviews
Volume	15
Issue number	4
Early online date	23 Dec 2018
DOIs	https://doi.org/10.2174/1573403X15666181224113855
Publication status	Published - 2019

Keywords

Congenital heart disease
melody
percutaneous pulmonary valve implantation
right ventricular outflow tract dysfunction
sapien
transcatheter pulmonary valve replacement.
transcatheter pulmonary valve replacement

Access to Document

10.2174/1573403X15666181224113855

Cite this

@article{d9f846b1717345288e59e61eed6c3dfc,

title = "Percutaneous pulmonary valve implantation: Current status and future perspectives",

abstract = "Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.",

keywords = "Congenital heart disease, melody, percutaneous pulmonary valve implantation, right ventricular outflow tract dysfunction, sapien, transcatheter pulmonary valve replacement., transcatheter pulmonary valve replacement",

author = "Bart Driesen and Evangeline Warmerdam and Sieswerda, \{Gertjan Tj\} and Folkert Meijboom and Mirella Molenschot and Gregor Krings and A.P. Dijk and Michiel Voskuil",

note = "Publisher Copyright: {\textcopyright} 2019 Bentham Science Publishers.",

year = "2019",

doi = "10.2174/1573403X15666181224113855",

language = "English",

volume = "15",

pages = "262--273",

journal = "Current Cardiology Reviews",

issn = "1573-403X",

publisher = "Bentham Science Publishers",

number = "4",

}

TY - JOUR

T1 - Percutaneous pulmonary valve implantation

T2 - Current status and future perspectives

AU - Driesen, Bart

AU - Warmerdam, Evangeline

AU - Sieswerda, Gertjan Tj

AU - Meijboom, Folkert

AU - Molenschot, Mirella

AU - Krings, Gregor

AU - Dijk, A.P.

AU - Voskuil, Michiel

PY - 2019

Y1 - 2019

N2 - Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

AB - Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

KW - Congenital heart disease

KW - melody

KW - percutaneous pulmonary valve implantation

KW - right ventricular outflow tract dysfunction

KW - sapien

KW - transcatheter pulmonary valve replacement.

KW - transcatheter pulmonary valve replacement

UR - https://www.scopus.com/pages/publications/85071623703

U2 - 10.2174/1573403X15666181224113855

DO - 10.2174/1573403X15666181224113855

M3 - Review article

C2 - 30582483

SN - 1573-403X

VL - 15

SP - 262

EP - 273

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

IS - 4

ER -

Percutaneous pulmonary valve implantation: Current status and future perspectives

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this